Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Autologous transplantation for multiple myeloma.

Trial Profile

Autologous transplantation for multiple myeloma.

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Melphalan (Primary) ; Cyclophosphamide; Granulocyte colony-stimulating factors
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Feb 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
    • 12 Feb 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
    • 12 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top